VYNE Therapeutics to Present at the Cantor Fitzgerald Investment Conference

September, 20 2021

BRIDGEWATER, N.J., Sept. 20, 2021 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that David Domzalski, Chief Executive Officer, will present at the Cantor Fitzgerald Virtual Global Healthcare Conference, to take place September 27th – 30th. The presentation will take the form of a fireside chat, which will be archived here for 90 days. Management will also be available for 1-on-1 meetings with investors. Presentation details  Date:  September 28th Time:  4pm ET Webcast: https://wsw.com/webcast/cantor12/vyne/2115540 About VYNE Therapeutics Inc.VYNE’s mission is to improve the lives of patients by developing proprietary, innovative, and differentiated therapies for…

Read More

VYNE Therapeutics to Present at the H.C. Wainwright Annual Investment Conference

September, 08 2021

BRIDGEWATER, N.J., Sept. 08, 2021 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that David Domzalski, Chief Executive Officer, will present at the H.C. Wainwright 23rd Annual Global Investment Conference to be held virtually from September 13th – 15th. The presentation will take the form of a fireside chat, which will be available on demand here beginning September 13th at 7:00 AM (ET) and archived for 90 days. Management will also be available for 1-on-1 meetings with investors. Date: September 13 Time: On Demand, beginning at 7:00 AM (ET) Webcast: VYNE Fireside Chat For…

Read More